Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5 publications
Phase 2 study of talabostat, a small molecule inhibitor of dipeptidyl peptidases (DPP), administered in combination with pembrolizumab in patients with small cell neuroendocrine prostate cancer.
Journal: Journal for immunotherapy of cancer
Published: April 24, 2026
Transient Serpentine Supravenous Erythema During Rapid Drug Desensitization.
Journal: The journal of allergy and clinical immunology. In practice
Published: June 12, 2024
A Phase I Study of Capivasertib in Combination With Abiraterone Acetate in Patients With Metastatic Castration-Resistant Prostate Cancer.
Journal: Clinical genitourinary cancer
Published: August 31, 2022
Receptor Tyrosine Kinase Fusions and BRAF Kinase Fusions are Rare but Actionable Resistance Mechanisms to EGFR Tyrosine Kinase Inhibitors.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: March 31, 2018
Primary pulmonary carcinoid tumor with metastasis to endometrial polyp.
Journal: International journal of surgery case reports
Published: July 17, 2012
Showing 1-5 of 5
Last Updated: 09/26/2026